Gregg Sutton Net Worth

The estimated Net Worth of Gregg S Sutton is at least 1.81 百万$ dollars as of 23 August 2018. Mr. Sutton owns over 14,824 units of Surmodics stock worth over 946,738$ and over the last 9 years he sold SRDX stock worth over 0$. In addition, he makes 864,905$ as Vice President - Research and Development、 Medical Devices at Surmodics.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Sutton SRDX stock SEC Form 4 insiders trading

Gregg has made over 1 trades of the Surmodics stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 14,824 units of SRDX stock worth 307,302$ on 23 August 2018.

The largest trade he's ever made was exercising 14,824 units of Surmodics stock on 23 August 2018 worth over 307,302$. On average, Gregg trades about 1,647 units every 0 days since 2016. As of 23 August 2018 he still owns at least 24,133 units of Surmodics stock.

You can see the complete history of Mr. Sutton stock trades at the bottom of the page.

Gregg Sutton biography

Gregg S. Sutton serves as Vice President - Research and Development, Medical Devices of the Company. He joined the Company in January 2016 as Vice President of Research and Development, Medical Devices. Prior to joining Surmodics, he served as President and CEO of NorMedix, Inc., which we acquired in fiscal 2016, since June 2009. Mr. Sutton is a veteran medical device designer and developer with over 25 years of engineering experience in the medical device industry. He co-founded and held executive positions at several highly successful, early-stage development device companies, including Atritech, Angioguard, Vascular Solutions, and Navarre Biomedical, leading teams in development and launch of high-profile, first-of-their-kind devices. With a degree in mechanical engineering and over 50 patents granted, he has substantial experience in all aspects of medical device development, including intellectual property, design, product development, and manufacturing.

What is the salary of Gregg Sutton?

As the Vice President - Research and Development、 Medical Devices of Surmodics, the total compensation of Gregg Sutton at Surmodics is 864,905$. There are 4 executives at Surmodics getting paid more, with Gary Maharaj having the highest compensation of 2,343,630$.

How old is Gregg Sutton?

Gregg Sutton is 60, he's been the Vice President - Research and Development、 Medical Devices of Surmodics since 2016. There are 5 older and 15 younger executives at Surmodics. The oldest executive at Surmodics, Inc. is David Dantzker, 76, who is the Independent Director.

What's Gregg Sutton's mailing address?

Gregg's mailing address filed with the SEC is 9924, West 74th Street, Eden Prairie, Hennepin County, Minnesota, 55344, United States of America.

Insiders trading at Surmodics

Over the last 21 years, insiders at Surmodics have traded over 26,204,565$ worth of Surmodics stock and bought 19,725 units worth 436,251$ . The most active insiders traders include Jeffrey C Smith、Gary R Maharaj、Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of 415,014$. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth 706,662$.

What does Surmodics do?

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.

Complete history of Mr. Sutton stock trades at Surmodics

Surmodics executives and stock owners

Surmodics executives and other stock owners filed with the SEC include:

• Gary Maharaj,
  President, Chief Executive Officer, Director
• Gary R. Maharaj,
  CEO, Pres & Director
• Teri Sides,
  Senior Vice President, Chief Marketing Officer
• Charles Olson,
  Senior Vice President of Commercial and Business Development, Medical Devices
• Gregg Sutton,
  Vice President - Research and Development, Medical Devices
• Thomas Greaney,
  Chief Operating Officer, Medical Devices
• Timothy Arens,
  Chief Financial Officer, Vice President - Finance
• Joseph Stich,
  Vice President, General Manager - In Vitro Diagnostics
• Gordon S. Weber,
  Sr. VP of Legal, Gen. Counsel & Sec.
• Timothy J. Arens,
  Sr. VP of Fin. & Information Technology and CFO
• Joseph J. Stich,
  Sr. VP and GM of HR & In Vitro Diagnostics
• Teryl L. W. Sides,
  Sr. VP of Product Devel. & Chief Marketing Officer
• Susan Knight,
  Non-Executive Independent Chairman of the Board
• Ronald Kalich,
  Independent Director
• David Dantzker,
  Independent Director
• Jose Bedoya,
  Independent Director
• Shawn McCormick,
  Independent Director
• Lisa Heine,
  Independent Director
• Nusrath Sultana,
  Vice President - Clinical Affairs
• Gordon Weber,
  Senior Vice President - Legal, General Counsel, Secretary
• Gregg S. Sutton,
  VP of R&D - Medical Devices
• Charles W. Olson,
  Sr. VP of Commercial & Bus. Devel. of Medical Devices
• John D. Manders,
  Corp. Controller & Principal Accounting Officer
• Lise W Duran,
  VP Product Development
• Andrew D. C. La Frence,
  VP of Finance & CFO
• Amy E. Seibert,
  Principal Accounting Officer
• Michael J Shoup,
  Vice President
• Douglas P Astry,
  General Manager
• Aron B Anderson,
  VP & Chief Scientific Officer
• John C. Middleton,
  VP, Drug Del, Product Dev
• Brian L Robey,
  Vice President
• Paul A Lopez,
  Vice President
• Bruce Barclay,
  President & COO
• John D. Manders,
  Corporate Controller
• Steven J Keough,
  VP & Chief IP Counsel
• Peter L Ginsberg,
  Vice President
• Bryan K Phillips,
  SVP, Gen Counsel & Secretary
• Kendrick B Melrose,
  Director
• David A Koch,
  Director
• Dale R Olseth,
  Chairman and CEO
• Loren R Miller,
  Vice President and Controller
• David S Wood,
  VP & GM - Drug Del. Bus. Unit
• Patrick E Guire,
  Senior Vice President
• Gregory T Yung,
  VP Sales & Business Developmen
• Ronald F Ofstead,
  VP Chemistry Development
• Richard C Carlson,
  VP of Strategic Planning
• Jane M Nichols,
  Vice President Marketing
• Marie J Versen,
  Vice President
• John W Benson,
  Director
• Mary K Brainerd,
  Director
• Mark A. Lehman,
  Treasurer
• Scott R. Ward,
  Director
• Gerald B Fischer,
  Director
• Timothy S Nelson,
  Director
• Robert C Buhrmaster,
  Director
• Eugene C. Rusch,
  VP, Manufacturing
• Value Lp Starboard Value Gp...,
  
• Philip D Ankeny,
  Chief Financial Officer
• Jeffrey C Smith,
  Director
• John A Meslow,
  Director
• Jan M Webster,
  Vice President, HR
• Arthur J Tipton,
  Vice President
• Kenneth H Keller,
  Director